Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Nuclear Medicine Market In 2029?

The dimension of the nuclear medicine market has undergone swift expansion in the last few years. Its growth is projected to rise from $8.93 billion in 2024 to $10.18 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.0%. Factors contributing to the development during the historical phase include an ageing populace, cancer detection and staging, cardiology uses, neurological ailments, as well as regulatory approvals.

In the upcoming years, the nuclear medicine market is anticipated to experience a swift expansion. The predicted growth will reach$15.64 billion by 2029 with a compound annual growth rate (CAGR) of 11.3%. This surge over the projection period can be ascribed to factors such as customized medicine, advancements in oncology and neurology research, sustainable operations, R&D initiatives, and telemedicine facilities. Key trends expected during the forecast timeline encompass radioimmunotherapy, hybrid imaging, the rise of artificial intelligence (AI), the emergence of novel radiopharmaceuticals, and progress in diagnostic imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What External and Internal Drivers Are Contributing to the Growth of theNuclear Medicine Market?

The surge in persistence and occurrence of cardiovascular disease (CVD) and cancer is predicted to drive the expansion of the nuclear medicine market in the future. Cardiovascular diseases include diverse disorders of the heart and blood vessels, while cancer signifies an illness where cells proliferate uncontrollably and infiltrate other body parts. Early diagnosis of cardiac diseases can be facilitated through nuclear cardiac imaging. Cancer treatment can be optimally administered using nuclear medicine therapy, either as a standalone method or in combination with other therapies like surgery and chemotherapy. Consequently, the escalating persistence and occurrence of cardiovascular disease coupled with cancer enhance the demand for the nuclear medicine market. For example, the American Cancer Society Inc., a non-profit health organization based in the US, anticipated 1,958,310 new cancer diagnoses in the US in January 2023, which presents an increase from over 1,918,030 new instances of the condition in 2022. Thus, the increasing persistence and occurrence of cardiovascular diseases and cancer stimulate the growth of the nuclear medicine market.

What Segment Types Define the Nuclear Medicine Market Structure?

The nuclear medicinemarket covered in this report is segmented –

1) By Type: Diagnostic; Therapeutic

2) By Application: Cardiology; Lymphoma; Thyroid; Neurology; Oncology; Other Application

3) By End-User: Hospitals and Clinics; Diagnostic Centers; Other End Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Gamma Cameras; Radiopharmaceuticals for Imaging; Other Diagnostic Imaging Techniques

2) By Therapeutic: Radiopharmaceuticals for Targeted Therapy; Beta Emitters; Alpha Emitters; Radiosynovectomy Agents; Other Therapeutic Applications

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Nuclear Medicine Market?

North America was the largest region in the nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Nuclear Medicine Market?

Leading corporations in the nuclear medicine market are channeling their efforts towards creating innovative solutions like nuclear medicine cyclotrons with an aim to boost production of radiopharmaceuticals and upgrade diagnostic imaging potential. These cyclotrons, specialized particle accelerators, generate radioactive isotopes for medical imaging and therapy by targeting high-energy particles at certain materials, which makes the creation of radiopharmaceuticals used in procedures like positron emission tomography (PET) possible. For example, in January 2024, GE Healthcare China, an American medical technology firm, unveiled its inaugural set of cyclotrons on December 1, 2023, in Chengdu Tianfu International Bio-Town. These sophisticated particle accelerators play a pivotal role in nuclear medicine as they facilitate production of medical isotopes for molecular imaging and therapeutic uses. This initiative is designed to develop a comprehensive infrastructure for nuclear medicine, thereby improving early disease detection and individualized treatment capabilities.

View the full report here:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

What Is the Definition of the Nuclear Medicine Market?

Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7485

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model